Calypso Biotech is an immunotherapy biotech company, that discovers and develops monoclonal antibodies for the treatment of immune pathologies with large unmet medical needs. The Company's portfolio consists of two preclinical therapeutic antibodies that intercept key immune checkpoints involved in multiple immune pathologies.
|Employees (est.) (Mar 2020)||8|
Calypso Biotech total Funding
Calypso Biotech latest funding size
Time since last funding
|a year ago|
Calypso Biotech investors
|INKEF Capital, Johnson & Johnson Innovation, Gilde Healthcare, M Ventures|
When was Calypso Biotech founded?
Calypso Biotech was founded in 2013.
Who are Calypso Biotech key executives?
Calypso Biotech's key executives are Alain Vicari, Brian Feagan and Yolande Chvatchko.
How many employees does Calypso Biotech have?
Calypso Biotech has 8 employees.
Who are Calypso Biotech competitors?
Competitors of Calypso Biotech include Imara, Polyneuron and ReViral.
Where is Calypso Biotech headquarters?
Calypso Biotech headquarters is located at Chemin des Aulx, Plan-les-Ouates.
Where are Calypso Biotech offices?
Calypso Biotech has offices in Plan-les-Ouates and Amsterdam.
How many offices does Calypso Biotech have?
Calypso Biotech has 2 offices.
Receive alerts for 300+ data fields across thousands of companies